Piper Sandler lowered the firm’s price target on Solventum (SOLV) to $92 from $98 and keeps an Overweight rating on the shares. The firm is making only minor changes to its model, including updates for currency movements and more appropriately reflecting GAAP restructuring charges in the P&L for 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV: